N-isopropyl-p-123I-amphetamine single photon emission computer tomography in motor neuron disease

European Neurology

Volumn 29, Issue 5, 1989, Pages 255-260

  Ludolph, A C ^a   Elger, C E ^b   Bottger I W ^a   Kuttig, A G ^a   Lottes, G ^b   Brune, G G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Degenerative disease; Motor neuron disease; N Isopropyl p 123I amphetamine; Single photon emission computer tomography

Indexed keywords

RADIOISOTOPE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL ARTICLE; COMPUTER ANALYSIS; FEMALE; HUMAN; MALE; MOTOR NEURON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AMPHETAMINES; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; FEMALE; HUMAN; IOFETAMINE; MALE; MIDDLE AGE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0024394316     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000116422     Document Type: Article

References (28)

1. Benson, D.F.; Kuhl D.E.; Hawkins, R.A.; Phelps, M.E.; Cummings, J.L.; Tsal, S.Y.: The fluorodeoxyglucose 18F scan in Alzheimer’s disease and multi-infarct dementia, Archs Neurol. 40: 711-714 (1983).
2. Calne, D.B.; Eisen, A.; McGeer, E.; Spencer, P.S.: Alzheimer’s disease. Parkinson’s disease, and motor neuron disease. Abio-trop(h)ic interaction between ageing and environment? Lancet 2: 1067-1069(1986).
3. Cosi, V.; Poloni, M.; Mazzini, L.; Callieco, R.: Somatosensory evoked potentials in amyotrophic lateral sclerosis. J. Neurol, Neurosurg. Psychiat. 47: 857-861 (1984).
4. Culler, N.R.; Haxby, J.V.; Duara, R.; Grady, C.L.; Moore, A.M.; Parisi, J.E.; While, J.: Heston, L; Margolin, R.M.; Rapoport, S.I.: Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer’s disease. Neurology 35: 1556-1561 (1985).
5. Dalakas, M.C.; Hatazawa, J.; Brooks, R.; Di Chiro, G.: Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann. Neurol. 22: 580-586 (1987)
6. Duara, R.; Grady, C; Haxby, I.; Sundaram, M.; Cutler, N.R.; Heston, L.; Moore, A.; Schlageter, N.; Larson, S.: Rapoport, S.I.: Positron emission tomography in Alzheimer’s disease. Neurology 36: 879-887 (1986).
7. Elger, CE.; Speckmann, E.J.: Mechanisms controlling the spatial extent of epileptic foci; in Wieser, Speckmann, Engel; The epileptic focus, pp. 45-58 (Libbey, London 1986).
8. Hirano, A.: Neuropathology of amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam; in Luthy, Bischoff. Proceedings of Ihc 5th International Congress of Neuropathology. Excerpta Med Int. Congr. Ser., No. 100, p. 190 (1966).
9. Holraan, B.L.; Hill, T.C.; Lee, R.G.L.; Zimmerman, R.E.; Moore, S.C.; Royal, H.D.: Brain imaging wilh radiolabeled amines; in Freeman. Weissman. Nuclear medicine annual, pp. 12-46 (Raven Press, New York 1983).
10. Holman B.L.; Hill, T.C.; Magistrctti, P.L.; Brain imaging with emission computed tomography and radiolabeled amines. Investve Radiol 17: 206-215 (1982).
11. Holman, B.L.; Hill, T.C.; Polak, J.F.; Lee, R.G.L.; Royal, H.D.; O’Leary, D.H.; Cerebral perfusion imaging with iodine-123-labeled amines. Arehs Neurol.41; 1060-1063 (1984).
12. Hughes J.T.: Pathology of amyotrophic lateral sclerosis; in Rowland; Human motor neuron diseases, pp. 67-74 (Raven Press, New York 1982).
13. Ingvar, D.H.: Regional cerebral blood flow in focal cortical epilepsy. Stroke. 4:359-360(1973).
14. Ingvar, D.H.; Functional landscapes of the dominant hemisphere. Brain Res. 707: 181-197(1976).
15. Kobayashi, H.; Hayashi, M.; Kawano, H.; Handa, Y.; Nozaki, J.; Yamamoto, S.; Matsuda, H.: Cerebral blood flow studies using N-isopropyl-I-123-iodoamphetamine. Stroke 16: 293-296 (1985).
16. Kontos, H.A.: Regulation of cerebral circulation. A. Rev. Physiol. 43:397-407(1981).
17. Kuhl, D.E.; Huang, S.C.; Selin, C; Ackermann, R.F.; Lear, J.L.; Wu, J.L.; Lin, T.H.; Phelps, M.E.: Quantifying local cerebral blood flow by N-isopropyl-p-(i;3-l)iodoamphetamine (IMP) tomography. J. nucl. Med. 23: 196-203 (1982).
18. Kuhl, D.E.; Wu, J.L.; Lin, T.H.; Selin, C; Phelps, M.: Mapping local cerebral blood flow by means of emission computed tomography of N-isopropyl-p-(l23-I)-Iodamphetamine (IMP). J Cereb. Blood Flow Metab. 1: suppl. 1, pp. 25-26 (1981).
19. Kurland, L.T.; Mulder, D.W.: Overview of motor neuron disease. Proc. Int. Meet. Motor Neuron Diseases, Bangalore, 1984.
20. Lee, R.G.; Hill, T.C.; Holman, B.L.; Clouse, M.Z.: N-isopropyl-(p-l23)-p-iodoamphetamine brain scans with single photon emission tomography: discordance with transmission tomography. Radiology 145: 795-799 (1982)
21. Lee, B.I.; Markand, O.N.; Siddiqui, A.R.; Park, H.M.: Mock, B.; Wellman, H.H.; Worth, R.M.; Edwards, M.K.: Single photon emission computed tomography (SPECT) brain imaging using N, N.NMrimethyl-N’-(2-hydroxy-3-rnelhyl-5-l23-I-iodobenzyl)-1, 3-propanediamine-2 HC1 (H1PDM); intractable complex partial seizures. Neurology 36: 1471-1477(1986).
22. Magisiretti, P.L.; Uren, R.F.; Shomer, D.; Blume, H.; Holman, B.; Hill, T.: Emission tomographic scans of cerebral blood flow using 1-124-iodoamphetamine in epilepsy; in Raynaud, Proceedings of the 3rd World Congress of Nuclear Medicine and Biology: Nuclear Medicine and Biology, pp. 139-143 (Pergamon Press, New York 1983).
23. Matheson, J.K.; Harrington, R.: Hallet, M.: Abnormalities of somatosensory, visual and brainstem evoked potentials in amyotrophic lateral sclerosis. Muscle Nerve 6: 529 (1983).
24. Mulder, D.W.: Clinical limits of amyotrophic lateral sclerosis; in Rowland, Human motor neuron diseases, pp. 15-22 (Raven Press, New York 1982).
25. Norris, F.H.; Calanchini, P.R.; Fallal, R.J.; Panchari, S.; Jewctt, B.; The administration of guanidine in amyotrophic lateral sclerosis. Neurology 24: 721-728 (1971).
26. Radtke, A.R.; Erwin, A.; Erwin, C.W.: Abnormal sensory evoked potentials in amyotrophic lateral sclerosis. Neurology 36: 796801 (1986).
27. Spencer, P.S.; Hugon, I: Ludolph, A.C.; Nunn, P.B.; Ross, S.R.: Roy, D.N.; Schaumburg, H.H.: Discovery and partial characterization of primate motor-system neurotoxins, in Boch. O’Connor, Selective neuronal death, Ciba Fdn Symp. No. 126. pp. 221-231 (Wiley, London 1987).
28. Tandon, R.; Bradley, W.G.: Amyotrophic lateral sclerosis. 2. Elio-pathogenesis. Ann. Neurol. 18: 252-266 (1985).